Y-mAbs Therapeutics, Inc. (YMAB)

Y-mAbs Therapeutics Statistics

Total Valuation

YMAB has a market cap or net worth of $455.95 million. The enterprise value is $405.03 million.

Market Cap	455.95M
Enterprise Value	405.03M

Important Dates

The last earnings date was Friday, November 8, 2024, before market open.

Earnings Date	Nov 8, 2024
Ex-Dividend Date	n/a

Share Statistics

YMAB has 44.79 million shares outstanding. The number of shares has increased by 0.82% in one year.

Current Share Class	44.79M
Shares Outstanding	44.79M
Shares Change (YoY)	+0.82%
Shares Change (QoQ)	+1.37%
Owned by Insiders (%)	2.63%
Owned by Institutions (%)	49.10%
Float	27.07M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	5.49
Forward PS	3.90
PB Ratio	5.10
P/TBV Ratio	5.08
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	4.79
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.92, with a Debt / Equity ratio of 0.01.

Current Ratio	3.92
Quick Ratio	3.48
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -24.78% and return on invested capital (ROIC) is -15.33%.

Return on Equity (ROE)	-24.78%
Return on Assets (ROA)	-11.98%
Return on Capital (ROIC)	-15.33%
Revenue Per Employee	$845,530
Profits Per Employee	-$238,640
Employee Count	100
Asset Turnover	0.68
Inventory Turnover	1.13

Taxes

In the past 12 months, YMAB has paid $801,000 in taxes.

Income Tax	801,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +94.48% in the last 52 weeks. The beta is 0.67, so YMAB's price volatility has been lower than the market average.

Beta (5Y)	0.67
52-Week Price Change	+94.48%
50-Day Moving Average	13.76
200-Day Moving Average	13.75
Relative Strength Index (RSI)	22.37
Average Volume (20 Days)	274,061

Short Selling Information

The latest short interest is 4.01 million, so 8.96% of the outstanding shares have been sold short.

Short Interest	4.01M
Short Previous Month	4.25M
Short % of Shares Out	8.96%
Short % of Float	14.82%
Short Ratio (days to cover)	24.40

Income Statement

In the last 12 months, YMAB had revenue of $84.55 million and -$23.86 million in losses. Loss per share was -$0.54.

Revenue	84.55M
Gross Profit	75.11M
Operating Income	-23.95M
Pretax Income	-23.97M
Net Income	-23.86M
EBITDA	-23.35M
EBIT	-23.95M
Loss Per Share	-$0.54

Balance Sheet

The company has $68.12 million in cash and $1.08 million in debt, giving a net cash position of $67.05 million or $1.50 per share.

Cash & Cash Equivalents	68.12M
Total Debt	1.08M
Net Cash	67.05M
Net Cash Per Share	$1.50
Equity (Book Value)	92.43M
Book Value Per Share	2.06
Working Capital	73.77M

Cash Flow

Operating Cash Flow	-21.88M
Capital Expenditures	n/a
Free Cash Flow	-21.88M
FCF Per Share	-$0.49

Margins

Gross margin is 88.83%, with operating and profit margins of -28.32% and -28.22%.

Gross Margin	88.83%
Operating Margin	-28.32%
Pretax Margin	-27.28%
Profit Margin	-28.22%
EBITDA Margin	-27.62%
EBIT Margin	-28.32%
FCF Margin	-14.50%

Dividends & Yields

YMAB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.82%
Shareholder Yield	-0.82%
Earnings Yield	-5.22%
FCF Yield	-4.78%

Analyst Forecast

The average price target for YMAB is $21.56, which is 111.79% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$21.56
Price Target Difference	111.79%
Analyst Consensus	Strong Buy
Analyst Count	9
Revenue Growth Forecast (5Y)	24.42%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

YMAB has an Altman Z-Score of 5.71 and a Piotroski F-Score of 2.

Altman Z-Score	5.71
Piotroski F-Score	2